Map the field
We scanned emerging and existing technologies and players across point of care molecular diagnostics.
A global diagnostics provider wanted to anticipate where the next point of care technologies would come from and how they work. We mapped emerging and existing players across more than 10 areas of molecular diagnostics.
The client is a global diagnostics provider active in molecular testing. It wanted to anticipate the next point of care technologies as care shifts toward test and treat models.
Prescouter was asked to profile and map new point of care diagnostics innovations, anticipating the next breakthrough technologies while explaining how these new tools actually function.
Find where the next tools will emerge.
Understand the technical details.
Track a shift in how care is delivered.
We scanned emerging and existing technologies and players across point of care molecular diagnostics.
We investigated intellectual property and guidelines to see where new diagnostic tools are heading.
Subject matter experts helped interpret secondary findings and regulatory signals.
Prescouter helped the client monitor upcoming technologies across more than 10 areas of molecular diagnostics development. The team also assessed products for their likelihood of successful implementation, helping the client adapt its innovation strategy to market demands.
Monitored for upcoming technologies.
Products rated for their chance of success.
Aligned with market demand.
In fast moving diagnostics, the best time to understand a technology is before it reaches the market. Steady monitoring turns surprises into options.
Map the technologies, test the claims and act before the market moves. Wherever you’re starting from, we’ll help you get there.
Or email [email protected]Pick a time on our calendar right now.
If you’d like to know the outcome of your submission, please leave your email address